(NYSE: NVRO) Nevro's forecast annual revenue growth rate of -0.98% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.53%.
Nevro's revenue in 2024 is $419,146,000.On average, 7 Wall Street analysts forecast NVRO's revenue for 2024 to be $15,131,378,208, with the lowest NVRO revenue forecast at $15,083,077,287, and the highest NVRO revenue forecast at $15,254,697,316. On average, 7 Wall Street analysts forecast NVRO's revenue for 2025 to be $15,218,087,542, with the lowest NVRO revenue forecast at $14,355,378,388, and the highest NVRO revenue forecast at $15,617,422,617.
In 2026, NVRO is forecast to generate $15,885,681,959 in revenue, with the lowest revenue forecast at $15,488,145,521 and the highest revenue forecast at $16,559,084,478.